The Glitazone Class of Drugs as Carbonic Anhydrase Inhibitors—A Spin-Off Discovery from Fragment Screening
- Supplementary File 1:
ZIP-Document (ZIP, 1057 KiB)
Mueller, S.L.; Chrysanthopoulos, P.K.; Halili, M.A.; Hepburn, C.; Nebl, T.; Supuran, C.T.; Nocentini, A.; Peat, T.S.; Poulsen, S.-A. The Glitazone Class of Drugs as Carbonic Anhydrase Inhibitors—A Spin-Off Discovery from Fragment Screening. Molecules 2021, 26, 3010. https://doi.org/10.3390/molecules26103010
Mueller SL, Chrysanthopoulos PK, Halili MA, Hepburn C, Nebl T, Supuran CT, Nocentini A, Peat TS, Poulsen S-A. The Glitazone Class of Drugs as Carbonic Anhydrase Inhibitors—A Spin-Off Discovery from Fragment Screening. Molecules. 2021; 26(10):3010. https://doi.org/10.3390/molecules26103010
Chicago/Turabian StyleMueller, Sarah L., Panagiotis K. Chrysanthopoulos, Maria A. Halili, Caryn Hepburn, Tom Nebl, Claudiu T. Supuran, Alessio Nocentini, Thomas S. Peat, and Sally-Ann Poulsen. 2021. "The Glitazone Class of Drugs as Carbonic Anhydrase Inhibitors—A Spin-Off Discovery from Fragment Screening" Molecules 26, no. 10: 3010. https://doi.org/10.3390/molecules26103010